The evidence for the use of MRI in the diagnosis and treatment of prostate cancer has been building.
However, more studies are needed to assess the accuracy of including MRI in the diagnostic process as compared to current diagnostic practices.
A study published in The Lancet Online assessed the accuracy of multi-parametric MRI amongst men with elevated PSA levels who have not had a previous biopsy. The results suggest that up to 27% of these men could avoid biopsies and the associated side-effects if mp-MRI was included in the diagnostic pathway. Importantly, a substantially higher proportion of clinically significant cancers can be detected with the use of MRI-guided biopsy.